BACKGROUND: Metastasis is the most important predictor of survival in patients with oral squamous cell carcinoma (OSCC). We tested the hypothesis that there is a genetic expression profile associated with OSCC metastasis. METHODS: We obtained samples from 6 OSCC node-positive primary tumors and their matched metastatic lymph nodes, and 5 OSCC node-negative primary tumors. Using laser capture microdissection, we isolated OSCC cells from metastatic lymph nodes and compared them with those from matched primary tumors and unmatched node-negative primary tumors using Affymetrix Human Genome Focus arrays. RESULTS: Comparison of tumor cells from the lymph nodes with those from the unmatched, node-negative primary tumors revealed differential expression of 160 genes. Hierarchical clustering and principal component analysis using this 160-gene set showed that the node-negative samples were distinguishable from both, node-positive primary tumors and tumors in the lymph nodes. Many of the expression changes found in the metastatic cells from the lymph nodes were also found in the node-positive primary tumors. Immunohistochemical analysis for transglutaminase-3 and keratin 16 confirmed the differential genetic expression for these genes. CONCLUSION: These preliminary results suggest that there may be a metastatic gene expression profile present in node-positive primary OSCC. (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.
BACKGROUND: Metastasis is the most important predictor of survival in patients with oral squamous cell carcinoma (OSCC). We tested the hypothesis that there is a genetic expression profile associated with OSCC metastasis. METHODS: We obtained samples from 6 OSCC node-positive primary tumors and their matched metastatic lymph nodes, and 5 OSCC node-negative primary tumors. Using laser capture microdissection, we isolated OSCC cells from metastatic lymph nodes and compared them with those from matched primary tumors and unmatched node-negative primary tumors using Affymetrix Human Genome Focus arrays. RESULTS: Comparison of tumor cells from the lymph nodes with those from the unmatched, node-negative primary tumors revealed differential expression of 160 genes. Hierarchical clustering and principal component analysis using this 160-gene set showed that the node-negative samples were distinguishable from both, node-positive primary tumors and tumors in the lymph nodes. Many of the expression changes found in the metastatic cells from the lymph nodes were also found in the node-positive primary tumors. Immunohistochemical analysis for transglutaminase-3 and keratin 16 confirmed the differential genetic expression for these genes. CONCLUSION: These preliminary results suggest that there may be a metastatic gene expression profile present in node-positive primary OSCC. (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.
Authors: Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto Journal: Clin Cancer Res Date: 2018-12-20 Impact factor: 12.531
Authors: Nicholas A Serrano; Chang Xu; Yan Liu; Pei Wang; Wenhong Fan; Melissa P Upton; John R Houck; Pawadee Lohavanichbutr; Michael Kao; Lue Ping Zhao; Stephen M Schwartz; Chu Chen; Eduardo Méndez Journal: Otolaryngol Head Neck Surg Date: 2012-04-02 Impact factor: 3.497
Authors: Chang Xu; Yan Liu; Pei Wang; Wenhong Fan; Tessa C Rue; Melissa P Upton; John R Houck; Pawadee Lohavanichbutr; David R Doody; Neal D Futran; Lue Ping Zhao; Stephen M Schwartz; Chu Chen; Eduardo Méndez Journal: Mol Cancer Date: 2010-06-11 Impact factor: 27.401
Authors: Eduardo Méndez; John R Houck; David R Doody; Wenhong Fan; Pawadee Lohavanichbutr; Tessa C Rue; Bevan Yueh; Neal D Futran; Melissa P Upton; D Gregory Farwell; Patrick J Heagerty; Lue Ping Zhao; Stephen M Schwartz; Chu Chen Journal: Clin Cancer Res Date: 2009-02-15 Impact factor: 12.531